Hastings Carl W

Reliv International, Inc.

Chief Scientific Officer, Director

Avg. Two Year Performance

48% Avg. Purchase Return 22% Compound

22% Avg. Sale Return 11% Compound

Holdings: 598.79K shares

Last Three Months: 24-Aug-24 -- 23-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Other

Drugs

Two Year Chart

24-Nov-22 -- 23-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions